US authorities arrest former Canadian pharmacy owner
Phil Taylor, 15-Jun-2012
One of the prominent figures in
the Canadian pharmacy sector in recent years - Andrew Strempler -
has been arrested in Florida on charges relating to the
distribution of illegal medicines in the US supply chain.
The 38-year-old is expected to be formally charged next week in a
Miami federal court for conspiracy to commit mail fraud and wire
fraud stemming from an online pharmacy business, according to a
Wall Street Journal report.
The arrest is the latest development in a long-running federal
investigation in to Canadian pharmacies linked to the introduction
of counterfeit, diverted and unapproved medicines into the US, and
has come to the fore once again after counterfeit copies of Roche's
cancer drug Avastin (bevacizumab) and Teva's attention-deficit
hyperactivity disorder (ADHD) were discovered earlier this
year.
Strempler was instrumental in setting up the Canadian Internet
pharmacy phenomenon which emerged around a decade ago in answer to
rising prescription drug prices in the US, providing cheaper
prescription medicines to American citizens via his Mediplan
Pharmacy business and RxNorth website.
In 2005 however the US FDA seized a large quantity of medicines
handled by Strempler's organisation and revealed that the majority
came from overseas manufacturers even though they were presented as
being made in Canada and approved by the national regulatory
authorities.
Further seizures a year later netted some counterfeit products,
according to federal documents, including fake versions of Pfizer's
cholesterol-lowerer Lipitor (atorvastatin) and AstraZeneca's
gastrintestinal drug Nexium (esomeprazole) and breast cancer
treatment Arimidex (anastrozole).
Although the RxNorth site was sold off in 2006 to CanadaDrugs.com
and evenually closed down in 2008, Strempler has continued to
operate an online pharmacy business outside Canada, namely
Pharmacheck which is based in the Caribbean island of Curacao.
Meanwhile, CanadaDrugs.com and a string of other overseas sites are
still being investigated by the FDA in connection with counterfeit
medicine cases.
The FDA's official line is that importation of medicines brought
from overseas online pharmacies remains illegal, and the agency
advises consumers only to buy drugs from online pharmacies
certified by the National Association of Boards of Pharmacy's
Verified Internet Pharmacy Practices Sites (VIPPS) programme.
An amendment to the Prescription Drug User Fee (PDUFA) seeking to
legalise personal importation of prescription medicines from Canada
was defeated in the Senate last month.
©
SecuringIndustry.com